Ibrutinib

Ibrutinib is a targeted therapy medication used to treat certain types of blood cancer, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma, and Waldenström macroglobulinemia. It works by blocking a specific protein involved in the growth and survival of cancer cells.

Uses: Ibrutinib is primarily used to treat:

• Chronic lymphocytic leukemia (CLL)
• Mantle cell lymphoma
• Waldenström macroglobulinemia
• Other types of blood cancer as determined by a healthcare professional

Important Considerations (Prescription Required):

1. Severe Side Effects: Ibrutinib can cause severe side effects, including infections, bleeding, and heart problems. It is essential to consult with a healthcare professional before starting treatment.
2. Prescription Only: Ibrutinib is a prescription medication and should only be used under the guidance of a qualified medical professional.
3. Regular Monitoring: During treatment, regular monitoring is necessary to assess for side effects and adjust the dosage as needed.